Clinical Trial Update: A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating niraparib in combination therapies for metastatic castration-resistant prostate cancer; the study is active/not recruiting with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Prostatic Neoplasms, Castration-Resistant | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-11-18